بایگانی برچسب برای: Chronic

Resistant.Hypertension.in.Chronic.Kidney.Disease.[taliem.ir]

Resistant Hypertension in Chronic Kidney Disease

Hypertension has long been known to be a signifcant cardiovascular risk factor and remains one of the most preventable causes of premature, especially cardiovascular and renal, morbidity and mortality in both developed and developing countries . Hypertension accounts for, or contributes to, 62% of all strokes and 49% of all cases of heart disease responsible for 7.1 million deaths per year: approximately 13% of total world deaths . Antihypertensive trials consistently demonstrate a signifcant risk reduction beneft from lowering blood pressure. A reduction of 5 mmHg in diastolic pressure over 5 years is associated with a 42% relative reduction in stroke and a 14% relative reduction in the risk of an ischemic heart disease event . At the start of the millennium, the estimated number of adults with hypertension worldwide was 972 million, with that number expected to rise to 1.56 billion by 2025 . Blood pressure is a continuous variable that is normally distributed . There is no natural “cutoff” above which hypertension defnitely exists and one below which it defnitely does not. Indeed, the risk of stroke and ischemic heart disease events is continuously associated with blood pressure , with no evidence of a threshold value down to at least 115/75 mmHg . Above 115/70 mmHg, the risk of cardiovascular disease doubles for every 20/10 mmHg rise in BP across all the blood pressure ranges for both men and women .
Urological.and.Gynaecological.Chronic.Pelvic.[taliem.ir]

Urological and Gynaecological Chronic Pelvic Pain

Ancient texts from China, India, the Middle East and Ancient Egypt document the suffering from urogenital and pelvic pain. Remedies in those times included medicinal herbs, with narcotics to numb the pain. The Italian Renaissance heralded an enhanced interest in the structure and function of the human body that continued to the Enlightenment in the eighteenth century, a time when intense interest developed with regard to nervous system function and pain. The nineteenth century witnessed the emergence of gynaecology and urology as specialties and an increasing interest in women’s diseases. Although some progress in pain management was seen with the development of new surgical procedures, anaesthetic agents, antibiotics and aspirin, the addictive properties and easy accessibility of the opioids and cocaine became a medical and social dilemma. The rise of medical societies and patient support groups in the feld of urological and gynaecological chronic pelvic pain, particularly in the twentieth century, led to a new interest in research, diagnosis and treatment and the development of criteria, guidelines, standards and taxonomies.
Treatment.of.Chronic.Pain.Conditions.A.Comprehensive.Handbook.[taliem.ir]

Treatment of Chronic Pain Conditions

Chronic pain is a term that defnes a set of specifc medical conditions in which a patient suffers from pain for extended periods of time. While many interventional treatment options exist depending on the nature of the complaint and the patient’s overall well-being, otherwise, many patients are given opioid therapy by primary care and ER physicians. This chapter addresses several key national factors that are currently tied to chronic pain: a growing epidemic of opioid use in the United States which is partially attributable to the lack of physicians who were effectively trained to treat pain, and the result is a signifcant economic burden on the country.
Depression and Anxiety[taliem.ir]

Depression and Anxiety in Patients with Chronic Respiratory Diseases

Mood disorders are often eclipsed by the primary task of respiratory management in those with chronic respiratory diseases. This is likely for a variety of reasons, including that it is not the forte of the primary respiratory provider to identify and/or manage these symptoms, that the presenting problem is the respiratory illness itself and that resources to identify and manage quality of life issues and mood disorders are often lacking. Though pharmacological options are generally readily available, identification of the mood disturbance is, in itself, time-consuming and requires some expertise to properly identify. Additionally, resources of psychotherapists with expertise in behavioral medicine are lacking. The largest of psychosocial problems faced by those with respiratory illnesses might be the same issues as those faced by any patient facing significant medical challenges. Though there may be some common psychosocial difficulties between the patients who share specific medical disorders, to some degree, individual differences with regard to resilience, coping strategies, comorbid complications, disease manifestation, hardiness, meaning attributed to the disease, and psychosocial supports all influence the direction and toll the disease itself may take on the individual. Lazarus describes a pattern of appraisal which is critical to any stressors; this involves the person evaluating the threat of the stress as well as the resources they need to minimize, tolerate, or eradicate the stressor. This appraisal process is critical to the patient’s future steps of how to rally resources to address the needs for managing the illness. It is at this stage that the patient is in vital need of resources to facilitate decision making and that they are vulnerable to decompensation in decision processing if they cannot rally these resources.